ES2065737T3 - Derivados de acido mandelico substituidos como inhibidores de 5-lipoxigenasa. - Google Patents

Derivados de acido mandelico substituidos como inhibidores de 5-lipoxigenasa.

Info

Publication number
ES2065737T3
ES2065737T3 ES92113956T ES92113956T ES2065737T3 ES 2065737 T3 ES2065737 T3 ES 2065737T3 ES 92113956 T ES92113956 T ES 92113956T ES 92113956 T ES92113956 T ES 92113956T ES 2065737 T3 ES2065737 T3 ES 2065737T3
Authority
ES
Spain
Prior art keywords
mandelic acid
acid derivatives
derivatives substituted
inhibitors
lipoxigenase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92113956T
Other languages
English (en)
Inventor
Klaus-Helmut Dr Mohrs
Siegfried Dr Raddatz
Michael Dr Matzke
Romanis Fruchtmann
Armin Dr Hatzelmann
Christian Dr Kohlsdorfer
Reiner Prof Muller-Peddinghaus
Pia Dr Theisen-Popp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2065737T3 publication Critical patent/ES2065737T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Measurement Of Force In General (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LOS DERIVADOS DEL ACIDO MANDELICO SUSTITUIDO SE PUEDEN FABRICAR POR CONVERSION DE ESTERES GLIOXILICOS CON COMPUESTOS GRIGNARD. LOS DERIVADOS DEL ACIDO MANDELICO SUSTITUIDO SON APROPIADOS COMO SUSTANCIAS ACTIVAS EN PRODUCTOS FARMACEUTICOS, EN PARTICULAR, PARA PRODUCTOS FARMACEUTICOS INHIBIDORES DE LA SINTESIS DEL LEUCOTRIENO.
ES92113956T 1991-08-29 1992-08-17 Derivados de acido mandelico substituidos como inhibidores de 5-lipoxigenasa. Expired - Lifetime ES2065737T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4128681A DE4128681A1 (de) 1991-08-29 1991-08-29 Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
ES2065737T3 true ES2065737T3 (es) 1995-02-16

Family

ID=6439400

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92113956T Expired - Lifetime ES2065737T3 (es) 1991-08-29 1992-08-17 Derivados de acido mandelico substituidos como inhibidores de 5-lipoxigenasa.

Country Status (21)

Country Link
US (1) US5292769A (es)
EP (1) EP0529450B1 (es)
JP (1) JPH05194402A (es)
KR (1) KR930004270A (es)
AT (1) ATE115949T1 (es)
AU (1) AU643628B2 (es)
CA (1) CA2076929A1 (es)
CZ (1) CZ281501B6 (es)
DE (2) DE4128681A1 (es)
DK (1) DK0529450T3 (es)
ES (1) ES2065737T3 (es)
FI (1) FI101222B (es)
GR (1) GR3015457T3 (es)
HU (1) HU214577B (es)
IL (1) IL102949A (es)
MX (1) MX9204748A (es)
MY (1) MY110206A (es)
RU (1) RU2066315C1 (es)
SK (1) SK263992A3 (es)
TW (1) TW207995B (es)
ZA (1) ZA926536B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
US5512581A (en) * 1994-07-18 1996-04-30 Abbott Laboratories Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
HRP970330B1 (en) * 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines
US8719041B2 (en) * 2002-06-10 2014-05-06 Ebay Inc. Method and system for customizing a network-based transaction facility seller application
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
RU2006124843A (ru) 2003-12-12 2008-01-20 Уайт (Us) Хинолины, пригодные для лечения сердечно-сосудистого заболевания
KR20070090248A (ko) * 2004-12-18 2007-09-05 바이엘 헬스케어 아게 4-시클로알킬-치환된 테트라히드로퀴놀린 유도체 및 그의약제로서의 용도
US20100068301A1 (en) 2006-11-30 2010-03-18 Hutchinson John H Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
CA2938879C (en) 2014-02-04 2023-05-09 Bioscience Pharma Partners, Llc Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
MY110206A (en) 1998-02-28
CZ281501B6 (cs) 1996-10-16
HUT67137A (en) 1995-02-28
CA2076929A1 (en) 1993-03-01
SK279066B6 (sk) 1998-06-03
IL102949A (en) 1997-02-18
SK263992A3 (en) 1998-06-03
DE4128681A1 (de) 1993-03-04
KR930004270A (ko) 1993-03-22
HU9202780D0 (en) 1992-12-28
RU2066315C1 (ru) 1996-09-10
IL102949A0 (en) 1993-01-31
JPH05194402A (ja) 1993-08-03
FI101222B1 (fi) 1998-05-15
FI923841A7 (fi) 1993-03-01
HU214577B (hu) 1998-04-28
US5292769A (en) 1994-03-08
DE59201013D1 (de) 1995-02-02
ATE115949T1 (de) 1995-01-15
EP0529450A1 (de) 1993-03-03
FI923841A0 (fi) 1992-08-27
MX9204748A (es) 1993-02-01
DK0529450T3 (da) 1995-05-15
CZ263992A3 (en) 1993-08-11
AU2137192A (en) 1993-03-04
FI101222B (fi) 1998-05-15
ZA926536B (en) 1993-03-05
EP0529450B1 (de) 1994-12-21
TW207995B (es) 1993-06-21
AU643628B2 (en) 1993-11-18
GR3015457T3 (en) 1995-06-30

Similar Documents

Publication Publication Date Title
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
ES2097341T3 (es) Indoles sustituidos como farmacos para el tratamiento del sida.
UY26962A1 (es) Monohidrato cristalino, procedimiento para su preparación y su utilización para la preparación de un medicamento
IT1049276B (it) Esteri di acido ciclopropancarbossilico sostituito procedimento per la loro produzione e composizioni insetticide che li contengono come ingrediente attivo
ES2065737T3 (es) Derivados de acido mandelico substituidos como inhibidores de 5-lipoxigenasa.
AR209755A1 (es) Nuevos compuestos derivados de la 2-hidroxi-c1-4-alquil sustituido benzofenoxima,utiles como productos intermediarios,que son terapeuticamente inactivos y particularmente apropiados para la preparacion de los correspondientes derivados benzisoxozolicos biologicamente activos
MX9204110A (es) Derivados del acido quinolonacarboxilico y procedimiento para su preparacion.
IT1065393B (it) Impianto per la disinfezione mediante formolo
MX9304961A (es) Esteres del acido piridiloxi-acrilico y procedimiento para su obtencion.
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
ES2061485T3 (es) Procedimiento para la fabricacion de 3-alcoximetilcefalosporinas.
IT1050255B (it) Derivati tiazolici procedimento per la loro produzione e composizioni disinfestanti che li contengono come sostanza attiva
MX9205236A (es) Amino-propanos sustituidos, procedimientos para su preparacion y su utilizacion.
IT1094846B (it) Procedimento per produrre la vitamina b12 mediante fermentazione
IT7851955A0 (it) Procedimento per la produzione di derivati originali di 5h-benzo-ci cloepten-7-ammina e loro sali prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo
IT998147B (it) Composti polienici come disinfeo stanti e procedimento per la loro produzione
AR201797A1 (es) Procedimiento para la preparacion de esteres citricos, acido citrico o las sales del acido citrico
FI48831C (fi) Kasvinsuojeluaineina käytettävät 2-metyyli-5,6-dihydropyraani-3-karbon ihappoanilidit.
IT1054184B (it) Processo per la preparazione di esteri organici del fosforo
ES481271A1 (es) Procedimiento de preparacion de derivados de la l-cisteina.
IT1048417B (it) Composti fosfotioammidici particolarmente utili come regolatori di crescita delle piante, e procedimento per la loro preparazione
IT1053764B (it) Procedimento per la preparazione di composti del fosforo organici, utili in particolare come disinfestanti, e relativi prodotti disinfestanti

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 529450

Country of ref document: ES